{
  "CHEMBL4297844": {
    "ChEMBL ID": "CHEMBL4297844",
    "Preferred Name": "TRASTUZUMAB DERUXTECAN",
    "All Aliases": [
      "TRASTUZUMAB-DERUXTECAN (T-DXD)",
      "TRASTUZUMAB-DERUXTECAN",
      "FAM-TRASTUZUMAB DERUXTECAN-NXKI (T-DXD)",
      "TRASTUZUMAB DERUXTECAN (T-DXD)",
      "ENHERTU",
      "DATOPOTOMAB DERUXTECAN (DATO-DXD)",
      "TRASTUZUMAB DERUXTECAN",
      "TRASTUZUMAB-DERUXTECAN (T-DXD, DS-8201)",
      "TRASTUZUMAB DERUXTECAN (ENHERTU)",
      "TRASTUZUMAB DERUXTECAN (T-DXD, ENHERTU)",
      "TRASTUZUMAB-DERUXTECAN (DXD)",
      "MNC2-DERUXTECAN",
      "DS8201"
    ],
    "Primary Target Name": "Receptor protein-tyrosine kinase erbB-2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297844",
      "Preferred Name": "TRASTUZUMAB DERUXTECAN",
      "Max Phase": "4.0",
      "First Approval": 2019,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Receptor protein-tyrosine kinase erbB-2 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL1824",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA topoisomerase I inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1781",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0004142",
        "EFO Term": "colorectal neoplasm",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0009708",
        "EFO Term": "metastasis",
        "MeSH ID": "D009362",
        "MeSH Term": "Neoplasm Metastasis",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0008549",
        "EFO Term": "digestive system neoplasm",
        "MeSH ID": "D004067",
        "MeSH Term": "Digestive System Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000305",
        "EFO Term": "breast carcinoma",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000637",
        "EFO Term": "osteosarcoma",
        "MeSH ID": "D012516",
        "MeSH Term": "Osteosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005842",
        "EFO Term": "colorectal cancer",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001056",
        "EFO Term": "gastric cancer",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000503",
        "EFO Term": "gastric adenocarcinoma",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000984",
        "EFO Term": "inflammatory breast carcinoma",
        "MeSH ID": "D058922",
        "MeSH Term": "Inflammatory Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001951",
        "EFO Term": "colorectal carcinoma",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1781",
        "Pref Name": "DNA topoisomerase I",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P11387",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P11387",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1824",
        "Pref Name": "Receptor protein-tyrosine kinase erbB-2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04626",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0007166",
            "HGNC": "cell surface receptor signaling pathway"
          }
        ]
      }
    ]
  },
  "CHEMBL4297939": {
    "ChEMBL ID": "CHEMBL4297939",
    "Preferred Name": "DATOPOTAMAB DERUXTECAN",
    "All Aliases": [
      "DATO-DXD",
      "DATOPOTAMAB DERUXTECAN (DATO-DXD)",
      "DATOPOTAMAB DERUXTECAN"
    ],
    "Primary Target Name": "Tumor-associated calcium signal transducer 2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297939",
      "Preferred Name": "DATOPOTAMAB DERUXTECAN",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tumor-associated calcium signal transducer 2 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3856163",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA topoisomerase I inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1781",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0008903",
        "EFO Term": "lung cancer",
        "MeSH ID": "D008175",
        "MeSH Term": "Lung Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003968",
        "EFO Term": "angiosarcoma",
        "MeSH ID": "D006394",
        "MeSH Term": "Hemangiosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1781",
        "Pref Name": "DNA topoisomerase I",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P11387",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P11387",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL3856163",
        "Pref Name": "Tumor-associated calcium signal transducer 2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P09758",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P09758",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "CHEMBL3301589": {
    "ChEMBL ID": "CHEMBL3301589",
    "Preferred Name": "ENFORTUMAB VEDOTIN",
    "All Aliases": [
      "PADCEV",
      "ENFORTUMAB VEDOTIN-EJFV",
      "ENFORTUMAB-VEDOTIN",
      "ENFORTUMAB VEDOTIN"
    ],
    "Primary Target Name": "Nectin-4",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3301589",
      "Preferred Name": "ENFORTUMAB VEDOTIN",
      "Max Phase": "4.0",
      "First Approval": 2019,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Nectin-4 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3712928",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0008528",
        "EFO Term": "urothelial carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0003863",
        "EFO Term": "urogenital neoplasm",
        "MeSH ID": "D014565",
        "MeSH Term": "Urogenital Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0001187",
        "EFO Term": "urinary bladder cancer",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0008315",
        "EFO Term": "prostate cancer",
        "MeSH ID": "D064129",
        "MeSH Term": "Prostatic Neoplasms, Castration-Resistant",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002517",
        "EFO Term": "pancreatic ductal adenocarcinoma",
        "MeSH ID": "D021441",
        "MeSH Term": "Carcinoma, Pancreatic Ductal",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000601",
        "EFO Term": "Transitional Cell Carcinoma",
        "MeSH ID": "D002295",
        "MeSH Term": "Carcinoma, Transitional Cell",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0004180",
        "EFO Term": "benign urinary system neoplasm",
        "MeSH ID": "D014571",
        "MeSH Term": "Urologic Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL3712928",
        "Pref Name": "Nectin-4",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "Q96NY8",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "Q96NY8",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "CHEMBL1743082": {
    "ChEMBL ID": "CHEMBL1743082",
    "Preferred Name": "TRASTUZUMAB EMTANSINE",
    "All Aliases": [
      "TRASTUZUMAB EMTANSINE (T-DM1)",
      "TRASTUZUMAB EMTANSINE (T-DM1, KADCYLA)",
      "KADCYLA",
      "TRASTUZUMAB-EMTANSINE",
      "TRASTUZUMAB-EMTANSINE (DM1)",
      "TRASTUZUMAB EMTANSINE",
      "ADO-TRASTUZUMAB EMTANSINE (T-DM1)",
      "TRASTUZUMAB-EMTANSINE (T-DM1)"
    ],
    "Primary Target Name": "Receptor protein-tyrosine kinase erbB-2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL1743082",
      "Preferred Name": "TRASTUZUMAB EMTANSINE",
      "Max Phase": "4.0",
      "First Approval": 2013,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tansine",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Receptor protein-tyrosine kinase erbB-2 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1824",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000305",
        "EFO Term": "breast carcinoma",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0009708",
        "EFO Term": "metastasis",
        "MeSH ID": "D009362",
        "MeSH Term": "Neoplasm Metastasis",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001056",
        "EFO Term": "gastric cancer",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0001378",
        "EFO Term": "multiple myeloma",
        "MeSH ID": "D009101",
        "MeSH Term": "Multiple Myeloma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004669",
        "EFO Term": "salivary gland cancer",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0008170",
        "EFO Term": "ovarian cancer",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000984",
        "EFO Term": "inflammatory breast carcinoma",
        "MeSH ID": "D058922",
        "MeSH Term": "Inflammatory Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0000521",
        "EFO Term": "salivary gland carcinoma",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0011962",
        "EFO Term": "endometrial cancer",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1000294",
        "EFO Term": "HER2 Positive Breast Carcinoma",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1824",
        "Pref Name": "Receptor protein-tyrosine kinase erbB-2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04626",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0007166",
            "HGNC": "cell surface receptor signaling pathway"
          }
        ]
      }
    ]
  },
  "CHEMBL2109399": {
    "ChEMBL ID": "CHEMBL2109399",
    "Preferred Name": "T-DM1",
    "All Aliases": [
      "T-DM1",
      "T-PEG6-DM1",
      "P-PEG6-DM1"
    ],
    "Primary Target Name": "Receptor protein-tyrosine kinase erbB-2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL2109399",
      "Preferred Name": "T-DM1",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Receptor protein-tyrosine kinase erbB-2 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL1824",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1824",
        "Pref Name": "Receptor protein-tyrosine kinase erbB-2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04626",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0007166",
            "HGNC": "cell surface receptor signaling pathway"
          }
        ]
      }
    ]
  },
  "CHEMBL4298098": {
    "ChEMBL ID": "CHEMBL4298098",
    "Preferred Name": "TUSAMITAMAB RAVTANSINE",
    "All Aliases": [
      "SAR408701 (TUSAMITAMAB RAVTANSINE)"
    ],
    "Primary Target Name": "Carcinoembryonic antigen-related cell adhesion molecule 5",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4298098",
      "Preferred Name": "TUSAMITAMAB RAVTANSINE",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tansine",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Carcinoembryonic antigen-related cell adhesion molecule 5 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3712881",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "3.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL3712881",
        "Pref Name": "Carcinoembryonic antigen-related cell adhesion molecule 5",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P06731",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P06731",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "CHEMBL3545262": {
    "ChEMBL ID": "CHEMBL3545262",
    "Preferred Name": "SACITUZUMAB GOVITECAN",
    "All Aliases": [
      "SACITUZUMAB GOVITECAN (SG)",
      "SACITUZUMAB GOVITECAN",
      "SACITUZUMAB-GOVITECAN"
    ],
    "Primary Target Name": "Tumor-associated calcium signal transducer 2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3545262",
      "Preferred Name": "SACITUZUMAB GOVITECAN",
      "Max Phase": "4.0",
      "First Approval": 2020,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tumor-associated calcium signal transducer 2 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3856163",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA topoisomerase I inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1781",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000519",
        "EFO Term": "glioblastoma multiforme",
        "MeSH ID": "D005909",
        "MeSH Term": "Glioblastoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0008528",
        "EFO Term": "urothelial carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001512",
        "EFO Term": "endometrial carcinoma",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0008315",
        "EFO Term": "prostate cancer",
        "MeSH ID": "D064129",
        "MeSH Term": "Prostatic Neoplasms, Castration-Resistant",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0001187",
        "EFO Term": "urinary bladder cancer",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000702",
        "EFO Term": "small cell lung carcinoma",
        "MeSH ID": "D055752",
        "MeSH Term": "Small Cell Lung Carcinoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003863",
        "EFO Term": "urogenital neoplasm",
        "MeSH ID": "D014565",
        "MeSH Term": "Urogenital Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0002974",
        "EFO Term": "cervical cancer",
        "MeSH ID": "D002583",
        "MeSH Term": "Uterine Cervical Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004669",
        "EFO Term": "salivary gland cancer",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004986",
        "EFO Term": "urinary bladder carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1781",
        "Pref Name": "DNA topoisomerase I",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P11387",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P11387",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL3856163",
        "Pref Name": "Tumor-associated calcium signal transducer 2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P09758",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P09758",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "CHEMBL4297987": {
    "ChEMBL ID": "CHEMBL4297987",
    "Preferred Name": "ENAPOTAMAB VEDOTIN",
    "All Aliases": [
      "ANTI-AXL ADC",
      "TM4SF1-CMET MMAE BISPECIFIC ADC"
    ],
    "Primary Target Name": "Tubulin",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297987",
      "Preferred Name": "ENAPOTAMAB VEDOTIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Tyrosine-protein kinase receptor UFO binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL4895",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL4895",
        "Pref Name": "Tyrosine-protein kinase receptor UFO",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P30530",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P30530",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      }
    ]
  },
  "CHEMBL3990032": {
    "ChEMBL ID": "CHEMBL3990032",
    "Preferred Name": "TELISOTUZUMAB VEDOTIN",
    "All Aliases": [
      "TELISOTUZUMAB VEDOTIN (TELISO-V)",
      "TELISOTUZUMAB-VEDOTIN"
    ],
    "Primary Target Name": "Tubulin",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3990032",
      "Preferred Name": "TELISOTUZUMAB VEDOTIN",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Hepatocyte growth factor receptor binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3717",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000708",
        "EFO Term": "squamous cell lung carcinoma",
        "MeSH ID": "D002294",
        "MeSH Term": "Carcinoma, Squamous Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3717",
        "Pref Name": "Hepatocyte growth factor receptor",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P08581",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0004714",
            "HGNC": "transmembrane receptor protein tyrosine kinase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      }
    ]
  },
  "CHEMBL4594611": {
    "ChEMBL ID": "CHEMBL4594611",
    "Preferred Name": "PATRITUMAB DERUXTECAN",
    "All Aliases": [
      "PATRITUMAB DERUXTECAN",
      "U3-1402"
    ],
    "Primary Target Name": "Receptor tyrosine-protein kinase erbB-3",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4594611",
      "Preferred Name": "PATRITUMAB DERUXTECAN",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Receptor tyrosine-protein kinase erbB-3 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL5838",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA topoisomerase I inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1781",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1781",
        "Pref Name": "DNA topoisomerase I",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P11387",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P11387",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL5838",
        "Pref Name": "Receptor tyrosine-protein kinase erbB-3",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P21860",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P21860",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "CHEMBL4298209": {
    "ChEMBL ID": "CHEMBL4298209",
    "Preferred Name": "BELANTAMAB MAFODOTIN",
    "All Aliases": [
      "BELANTAMAB MAFODOTIN"
    ],
    "Primary Target Name": "Tumor necrosis factor receptor superfamily member 17",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4298209",
      "Preferred Name": "BELANTAMAB MAFODOTIN",
      "Max Phase": "4.0",
      "First Approval": 2020,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tumor necrosis factor receptor superfamily member 17 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL4523587",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0001378",
        "EFO Term": "multiple myeloma",
        "MeSH ID": "D009101",
        "MeSH Term": "Multiple Myeloma",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000403",
        "EFO Term": "diffuse large B-cell lymphoma",
        "MeSH ID": "D016403",
        "MeSH Term": "Lymphoma, Large B-Cell, Diffuse",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0019438",
        "EFO Term": "AL amyloidosis",
        "MeSH ID": "D028226",
        "MeSH Term": "Amyloidosis, Familial",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL4523587",
        "Pref Name": "Tumor necrosis factor receptor superfamily member 17",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "Q02223",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "Q02223",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      }
    ]
  },
  "CHEMBL3989983": {
    "ChEMBL ID": "CHEMBL3989983",
    "Preferred Name": "COFETUZUMAB PELIDOTIN",
    "All Aliases": [
      "COFETUZUMAB PELIDOTIN"
    ],
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3989983",
      "Preferred Name": "COFETUZUMAB PELIDOTIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "CHEMBL5095273": {
    "ChEMBL ID": "CHEMBL5095273",
    "Preferred Name": "DISITAMAB VEDOTIN",
    "All Aliases": [
      "DISITAMAB VEDOTIN"
    ],
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5095273",
      "Preferred Name": "DISITAMAB VEDOTIN",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0004142",
        "EFO Term": "colorectal neoplasm",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0008528",
        "EFO Term": "urothelial carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1001951",
        "EFO Term": "colorectal carcinoma",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001056",
        "EFO Term": "gastric cancer",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      }
    ],
    "Target Metadata": []
  },
  "CHEMBL4802212": {
    "ChEMBL ID": "CHEMBL4802212",
    "Preferred Name": "FARLETUZUMAB ECTERIBULIN",
    "All Aliases": [
      "FARLETUZUMAB ECTERIBULIN (FZEC)"
    ],
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4802212",
      "Preferred Name": "FARLETUZUMAB ECTERIBULIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-bulin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003893",
        "EFO Term": "ovarian neoplasm",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "CHEMBL4297778": {
    "ChEMBL ID": "CHEMBL4297778",
    "Preferred Name": "LONCASTUXIMAB TESIRINE",
    "All Aliases": [
      "LONCASTUXIMAB TESIRINE"
    ],
    "Primary Target Name": "B-lymphocyte antigen CD19",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297778",
      "Preferred Name": "LONCASTUXIMAB TESIRINE",
      "Max Phase": "4.0",
      "First Approval": 2021,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "B-lymphocyte antigen CD19 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3390821",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA cross-linking agent",
        "Action Type": "CROSS-LINKING AGENT",
        "Target ChEMBL ID": "CHEMBL2311221",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000220",
        "EFO Term": "acute lymphoblastic leukemia",
        "MeSH ID": "D054198",
        "MeSH Term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000403",
        "EFO Term": "diffuse large B-cell lymphoma",
        "MeSH ID": "D016403",
        "MeSH Term": "Lymphoma, Large B-Cell, Diffuse",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:1001938",
        "EFO Term": "B-cell non-Hodgkins lymphoma",
        "MeSH ID": "D016393",
        "MeSH Term": "Lymphoma, B-Cell",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0018906",
        "EFO Term": "follicular lymphoma",
        "MeSH ID": "D008224",
        "MeSH Term": "Lymphoma, Follicular",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000096",
        "EFO Term": "neoplasm of mature B-cells",
        "MeSH ID": "D008224",
        "MeSH Term": "Lymphoma, Follicular",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000309",
        "EFO Term": "Burkitts lymphoma",
        "MeSH ID": "D002051",
        "MeSH Term": "Burkitt Lymphoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0005952",
        "EFO Term": "non-Hodgkins lymphoma",
        "MeSH ID": "D008228",
        "MeSH Term": "Lymphoma, Non-Hodgkin",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0009441",
        "EFO Term": "Waldenstrom macroglobulinemia",
        "MeSH ID": "D008258",
        "MeSH Term": "Waldenstrom Macroglobulinemia",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001469",
        "EFO Term": "Mantle cell lymphoma",
        "MeSH ID": "D020522",
        "MeSH Term": "Lymphoma, Mantle-Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2311221",
        "Pref Name": "DNA",
        "Target Type": "NUCLEIC-ACID",
        "Organism": "Homo sapiens",
        "Target Components": []
      },
      {
        "Target ChEMBL ID": "CHEMBL3390821",
        "Pref Name": "B-lymphocyte antigen CD19",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P15391",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P15391",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "CHEMBL5095133": {
    "ChEMBL ID": "CHEMBL5095133",
    "Preferred Name": "LUVELTAMAB TAZEVIBULIN",
    "All Aliases": [
      "LUVELTAMAB TAZEVIBULIN"
    ],
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5095133",
      "Preferred Name": "LUVELTAMAB TAZEVIBULIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-bulin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "CHEMBL3545132": {
    "ChEMBL ID": "CHEMBL3545132",
    "Preferred Name": "MIRVETUXIMAB SORAVTANSINE",
    "All Aliases": [
      "MIRVETUXIMAB SORAVTANSINE-GYNX"
    ],
    "Primary Target Name": "Folate receptor alpha",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3545132",
      "Preferred Name": "MIRVETUXIMAB SORAVTANSINE",
      "Max Phase": "4.0",
      "First Approval": 2022,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tansine",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Folate receptor alpha binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL2121",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0002158",
        "EFO Term": "fallopian tube cancer",
        "MeSH ID": "D005185",
        "MeSH Term": "Fallopian Tube Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0008170",
        "EFO Term": "ovarian cancer",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0011962",
        "EFO Term": "endometrial cancer",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001100",
        "EFO Term": "peritoneal neoplasm",
        "MeSH ID": "D010534",
        "MeSH Term": "Peritoneal Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0018364",
        "EFO Term": "malignant epithelial tumor of ovary",
        "MeSH ID": "D000077216",
        "MeSH Term": "Carcinoma, Ovarian Epithelial",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0021092",
        "EFO Term": "fallopian tube neoplasm",
        "MeSH ID": "D005185",
        "MeSH Term": "Fallopian Tube Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2121",
        "Pref Name": "Folate receptor alpha",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P15328",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P15328",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      }
    ]
  },
  "CHEMBL4594576": {
    "ChEMBL ID": "CHEMBL4594576",
    "Preferred Name": "VOBRAMITAMAB DUOCARMAZINE",
    "All Aliases": [
      "VOBRAMITAMAB DUOCARMAZINE (VOBRA DUO)"
    ],
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4594576",
      "Preferred Name": "VOBRAMITAMAB DUOCARMAZINE",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0008315",
        "EFO Term": "prostate cancer",
        "MeSH ID": "D064129",
        "MeSH Term": "Prostatic Neoplasms, Castration-Resistant",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  }
}